Reading this on a mobile device? Try our optimized mobile version here: http://r.smartbrief.com/resp/eegSCfbwoceXqWwFwmzI

  ADVERTISEMENT  
January 3, 2013News for the transfusion medicine and cellular therapy community

  Top Story 
 
  • Dabigatran performs well in study
    The anticoagulant dabigatran performed safely and effectively in a group of 938 unselected patients with atrial fibrillation, according to a German study presented at a meeting. Less than 2% of the patients experienced major cardiovascular events, and 1% experienced minor cardiovascular events. Bleeding complications were experienced by 14.9% of patients, but only 1.5% faced major bleeding, the study found. Healio (1/2) LinkedInFacebookTwitterEmail this Story
  ADVERTISEMENT  
Quotient is on a roll with new FDA approvals & GPO contracts
More good news from Quotient! Not only do we have FDA-approved Reagent Red Blood Cells products, but also just approved Rare Antisera, including Anti-s and Anti-Wra. We also have new 3-yr agreements with Premier Inc. and the General Services Administration. Great products and value from the one manufacturer focused on manual testing. Contact us today.

  Science & Health 
  • Pediatric group issues guidelines on C. difficile infection
    The American Academy of Pediatrics released new guidelines urging providers to look for other possible causes whenever infants test positive for Clostridium difficile since they normally have high colonization rates with the bacteria. Infants should only be tested for C. difficile when there's an outbreak or when the patient has Hirschsprung disease or other severe motility disorders, the group said. "For children older than 3 years, testing can be performed in the same manner as for older children and adults," AAP said. MedPage Today (free registration) (1/2) LinkedInFacebookTwitterEmail this Story
  Emerging Trends 
  • Canadian clinic offers fat stem cell banking
    Adisave, a stem-cell collection clinic in Toronto, is offering a storage service for stem cells derived from body fat. Adisave is planning to conduct two studies to explore the potential of fat-derived stem cells to treat joints damaged by arthritis and to heal scars. CTV.ca (Canada) (1/1) LinkedInFacebookTwitterEmail this Story
  Industry News & Practice 
  • Report breaks down 5 ACO payment models
    The move to accountable care organizations presents leaders with the challenge of identifying which payment model would best help them achieve the ACO goals of better care quality and outcomes at reduced costs. An American Academy of Actuaries report describes the five common ACO payment schemes, which include one-sided shared savings and bundled payments. BeckersOrthopedicAndSpine.com (12/31) LinkedInFacebookTwitterEmail this Story
  • NanoViricides develops influenza drug candidate
    NanoViricides received an additional investment that will help advance its influenza drug candidate toward clinical studies and renovate a manufacturing facility in Shelton, Conn. The $2.5 million in financing was the second half of an investment from private equity company Seaside 88. New Haven Register (Conn.) (12/31) LinkedInFacebookTwitterEmail this Story
  Government & Regulatory 
  Association News 
  • AABB seeks next CEO
    AABB seeks a leader with a commitment to improving health care to serve as its next chief executive officer. This prestigious position offers an extraordinary opportunity to lead a respected national professional and scientific association that serves as a preeminent knowledge-based organization focused on improving health through advancing the science and practice of transfusion medicine and cellular therapies. The executive search firm Witt/Kieffer has been retained by AABB to assist in recruiting the new CEO. Those interested in applying for the position should visit the company's website for more details. LinkedInFacebookTwitterEmail this Story
Learn more about AABB® ->Homepage  |  Join AABB  |  Conferences  |  Marketplace

Position TitleCompany NameLocation
Performance Improvement ConsultantBlood Systems, Inc.US - AZ - Scottsdale
LABORATORY MANAGERUnited Blood ServicesUS - NV - Las Vegas
DIRECTOR, COMMUNITY CENTER IUnited Blood ServicesUS - NV - Reno
QA SpecialistSan Diego Blood BankUS - CA
Reference TechnologistLifeStreamUS - CA - San Bernardino
Click here to view more job listings.

  SmartQuote 
Well done is better than well said."
--Benjamin Franklin,
American inventor and statesman


LinkedInFacebookTwitterEmail this Story

 
 
Subscriber Tools
     
Print friendly format | Web version | Search past news | Archive | Privacy policy

Advertise
Corporate Relations Manager:  Tamara Zein (240) 333-6604
Job Board: AABB CareerLink
 
Read more at SmartBrief.com
A powerful website for SmartBrief readers including:
 
 
 Recent AABB SmartBrief Issues:   Lead Editor:  Tom Parks
Managing Editor: Cristian Becker

Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
 
 
© 1999-2013 SmartBrief, Inc.® Legal Information